D. Chen

Radiotherapy of 180 cases of operable esophageal carcinoma.

W. Yin, Dong-fu Chen, Z. Yang, 1997, World journal of gastroenterology.

Analysis of early hypertension (HTN) and clinical outcome with bevacizumab (BV).

G. Sledge, P. Douglas, H. Hurwitz, 2010 .

Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial

Wei Chen, Z. Zhou, Y. Shyr, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival comparision of three-dimensional radiotherapy alone with concurrent chemoradiotherapy for non-surgical esophageal carcinoma.

Z. Zhou, Q. Feng, W. Yin, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Results and prognostic factors of 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for esophageal carcinoma.

Z. Zhou, Q. Feng, W. Yin, 2015, Neoplasma.

1400P Vibostolimab, an anti-TIGIT antibody, as monotherapy and in combination with pembrolizumab in anti-PD-1/PD-L1-refractory NSCLC

M. Ahn, D. Rasco, E. Chartash, 2020, Annals of Oncology.

A SINGLE‐ARM, OPEN‐LABEL, PILOT TRIAL OF AUTOLOGOUS CD7‐CAR‐T CELLS FOR CD7 POSITIVE RELAPSED AND REFRACTORY T‐LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

X. Wang, Zhaoming Li, G. Pan, 2021, Hematological Oncology.

1137OInterim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)

R. Figlin, C. Wood, V. Master, 2017 .

[Study on safety of adjuvant radiotherapy concurrent with weekly chemotherapy for stage ⅡB-ⅣA esophageal carcinoma after radical resection].

Z. Zhou, N. Bi, T. Zhang, 2019, Zhonghua zhong liu za zhi [Chinese journal of oncology].